Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...

Below is Validea's guru fundamental report for ORACLE CORP (ORCL). Of the 22 guru strategies we follow, ORCL rates highest using our Growth Investor model based on the published strategy of Martin ...

Below is Validea's guru fundamental report for EXPEDIA GROUP INC (EXPE). Of the 22 guru strategies we follow, EXPE rates highest using our Growth Investor model based on the published strategy of ...

Between the rise of artificial intelligence, corporate consolidation, and the marginalization of the theatrical window, ...

Results and Investor Q&A to Be Released in Lieu of Investor Presentation Detroit, Michigan, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...

The U.S. poured $4.9 trillion into health care in 2023, equal to roughly 17.6% of GDP, federal data show. What jumps out from ...

The world tried to kill Andy off but he had to stay alive to to talk about what happened with databases in 2025.

The room we are in is locked. It is windowless and lit from above by a fluorescent bulb. In the hallway outside—two stories beneath the city of London—attendants in dark suits patrol silently, giving ...

Life’s too short for small talk. Rachel gets right to the questions that matter most. Once a week, famous guests pull questions from a deck of cards and open up about the kind of stuff we all think ...